These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7626348)

  • 1. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular volumes, ejection fraction, and plasma proatrial natriuretic factor (1-98) after withdrawal of enalapril treatment initiated early after myocardial infarction. CONSENSUS II Multi-Echo Study Group.
    Bonarjee VV; Omland T; Nilsen DW; Carstensen S; Berning J; Edner M; Caidahl K
    Br Heart J; 1995 Jun; 73(6):506-10. PubMed ID: 7626347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
    Choy AM; Darbar D; Lang CC; Pringle TH; McNeill GP; Kennedy NS; Struthers AD
    Br Heart J; 1994 Jul; 72(1):16-22. PubMed ID: 7741839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
    Omland T; Aakvaag A; Vik-Mo H
    Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.
    Luchner A; Hengstenberg C; Löwel H; Trawinski J; Baumann M; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2002 Jan; 39(1):99-104. PubMed ID: 11799086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Dobnig H; Schumacher M; Maier R; Zweiker R; Leb G; Klein W
    Heart; 1999 Nov; 82(5):630-3. PubMed ID: 10525523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
    Hole T; Hall C; Skaerpe T
    Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial filling fraction predicts left ventricular systolic function after myocardial infarction: pre-discharge echocardiographic evaluation].
    Galderisi M; Fakher A; Petrocelli A; Alfieri A; Garofalo M; de Divitiis O
    Cardiologia; 1995 Oct; 40(10):763-8. PubMed ID: 8819737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.
    Hall C; Ihlen H; Bonarjee V; Dickstein K; Kjekshus J
    Int J Cardiol; 2003 Jun; 89(2-3):197-205. PubMed ID: 12767543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure.
    Dickstein K; Larsen AI; Bonarjee V; Thoresen M; Aarsland T; Hall C
    Am J Cardiol; 1995 Oct; 76(10):679-83. PubMed ID: 7572624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure.
    Wijbenga AA; Balk AH; Jonkman FA; Boomsma F; Simoons ML; Man in t Veld AJ
    Eur J Heart Fail; 1999 Mar; 1(1):51-8. PubMed ID: 10937980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating atrial natriuretic factor concentrations in patients with chronic heart failure after inhibition of neutral endopeptidase: effects on diastolic function.
    Northridge DB; Jardine A; Henderson E; Dilly SG; Dargie HJ
    Br Heart J; 1992 Oct; 68(4):387-91. PubMed ID: 1449922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.